Promise Ledger
Every outstanding corporate promise with a resolution deadline — and the ones that just resolved. Descriptive, sourced, receipt-backed.
Guidance withheld · 47
A company that guided consistently, then went silent — a fact, not a forecast.- BAXWithheld quarterly guidance for Q1 2026 after 20 consecutive guided quartersJun 30, 2026
- EQRWithheld quarterly guidance for Q1 2026 after 7 consecutive guided quartersJun 30, 2026
- DASHWithheld quarterly guidance for Q1 2026 after 11 consecutive guided quartersJun 30, 2026
- TXNWithheld quarterly guidance for Q1 2026 after 6 consecutive guided quartersJun 30, 2026
- IEXWithheld quarterly guidance for Q4 2025 after 15 consecutive guided quartersMar 31, 2026
- DALWithheld quarterly guidance for Q4 2025 after 16 consecutive guided quartersMar 31, 2026
- PTCWithheld quarterly guidance for Q3 2025 after 7 consecutive guided quartersDec 30, 2025
- FTVWithheld quarterly guidance for Q3 2025 after 18 consecutive guided quartersDec 30, 2025
Dividend activity · 300
Declared dividends, shown as history — descriptive, not scored, no verdict.275 open · Buyback
- PTCBuybackexpect to repurchase approximately $300 million worth of our stock in FY’25resolves in ~53 days
- QCOMBuybackOur Board of Directors has also approved a new $15.0 billion stock repurchase authorization.resolves in ~53 days
- ABNBBuybackAs of September 30, 2024, we had $4.2 billion remaining under our $6 billion repurchase authorizationresolves in ~54 days
- BSQKZBuybackauthorized an increase to our share repurchase program of up to an additional $3 billionresolves in ~54 days
- CPAYBuybackThe Board is also announcing today an increase in the share repurchase authorization by $1 billionresolves in ~54 days
- VSTBuybackBoard authorized an additional $1.0 billion of share repurchasesresolves in ~54 days
- FTNTBuybackauthorized a $1.0 billion increase in the authorized stock repurchaseresolves in ~54 days
- NRGBuybackNRG's Board of Directors has approved an increase of the Company's share repurchase authorization through 2025 to $3.7 billion from $2.7 billion.resolves in ~55 days
- DISBuybackTargeting $3 billion in stock repurchasesresolves in ~61 days
- LULUBuybackthe board of directors approved a $1.0 billion increase to the Company's stock repurchase programresolves in ~82 days
- FDXBuybackThe company expects to repurchase an additional $500 million of common stock during fiscal 2025resolves in ~96 days
- SLBBuybackSLB entered into ASR transactions to repurchase $2.3 billion of its common stockresolves in ~125 days
- NFLXBuybackOur Board has approved an incremental $15B for the program which brings our total buyback authorization to $17.1Bresolves in ~129 days
- UNPBuybackShare repurchases of $4.0 to $4.5 billionresolves in ~131 days
- HCABuybackThe HCA Healthcare, Inc. Board of Directors has authorized an additional share repurchase program for up to $10 billion of the Company’s outstanding common stock.resolves in ~132 days
- AREBuybackauthorized a common stock repurchase program under which we may repurchase up to $500.0 millionresolves in ~135 days
- TMUSBuybackThe current authorization allows for stock repurchases and dividends through December 2025 of up to $14.0 billionresolves in ~137 days
- HSICBuybackthe Company’s Board of Directors has authorized an increase of $500 million to the Company’s stock repurchase programresolves in ~137 days
- CIBuybackbringing the company's total share repurchase authority to $10.3 billionresolves in ~138 days
- PHMBuybackthe Company announced that its Board of Directors approved a $1.5 billion increase to the Company’s share repurchase authorizationresolves in ~138 days
- GWWBuybackShare Buyback $1.15 - $1.25 billionresolves in ~139 days
- AONBuybackreturning capital to shareholders, including $1 billion in share repurchasesresolves in ~139 days
- IDXXBuybackOutlook assumes ~$1.5 billion of share repurchases in 2025resolves in ~142 days
- MTCHBuybackauthorized a new repurchase program of up to $1.5 billionresolves in ~143 days
- PTCBuybackWe currently intend to repurchase approximately $300 million of our common stock in FY’25resolves in ~144 days